Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CLGN
CLGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CLGN News
CollPlant Biotechnologies Reports FY 2025 Financial Results
4d ago
seekingalpha
CollPlant Reports 2025 Financial Results and Corporate Updates
4d ago
PRnewswire
CollPlant Faces Nasdaq Delisting Risk Due to Low Share Price
6d ago
PRnewswire
CollPlant Receives Nasdaq Warning on Share Price
6d ago
seekingalpha
CollPlant to Report 2025 Financial Results on March 26, 2026
Mar 11 2026
PRnewswire
CollPlant Launches BioFlex Bioink Kit for 3D Bioprinting
Feb 23 2026
PRnewswire
CollPlant Launches BioFlex Bioink for Advanced 3D Bioprinting
Feb 23 2026
Newsfilter
Wall Street Analysts Adjust Ratings on Top Stocks
Feb 06 2026
Benzinga
D. Boral Capital Upholds Buy Rating for CollPlant Biotechnologies (CLGN)
Nov 29 2025
NASDAQ.COM
D. Boral Capital Reiterates Buy Rating for CollPlant Biotechnologies with $12 Price Target Intact
Nov 28 2025
Benzinga
CollPlant Partners with U.S. Logistics Center to Expand North American Market
Nov 26 2025
Newsfilter
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Nov 26 2025
PRnewswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS
Nov 18 2025
PRnewswire
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
Oct 27 2025
PRnewswire
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
Oct 20 2025
PRnewswire
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
Oct 16 2025
PRnewswire
Show More News
